ELETRIPTAN HYDROBROMIDE vs ELRANATAMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ELETRIPTAN HYDROBROMIDE vs ELRANATAMAB: Safety Overview
| Metric | ELETRIPTAN HYDROBROMIDE | ELRANATAMAB |
|---|---|---|
| Total FAERS Reports | 2,158 | 758 |
| Deaths Reported | 12 | 177 |
| Death Rate | 0.6% | 23.4% |
| Hospitalizations | 271 | 482 |
| Average Patient Age | 52.6 yrs | 67.6 yrs |
| % Female Patients | 86.2% | 45.2% |
| FDA Approval Date | Aug 11, 2017 | N/A |
| Manufacturer | Zydus Pharmaceuticals USA Inc. | Pfizer Laboratories Div Pfizer Inc |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |